The effect of antibiotics on bone healing: Current evidence

Expert Opinion on Drug Safety

Volumn 10, Issue 6, 2011, Pages 935-945

  Pountos, Ippokratis ^a   Georgouli, Theodora ^a   Bird, Howard ^a   Kontakis, George ^b   Giannoudis, Peter V ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Antibiotics; Bone healing; Mesenchymal stem cells

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; CYTOKINE; GENTAMICIN; GROWTH FACTOR; LEVOFLOXACIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; TROVAFLOXACIN; VANCOMYCIN;

BONE REMODELING; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFECT; FRACTURE HEALING; HUMAN; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OSTEOBLAST; OTOTOXICITY; REVIEW; SYSTEMATIC REVIEW; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BONE AND BONES; FRACTURE HEALING; HUMANS;

EID: 80054742901     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2011.589833     Document Type: Review

References (83)

1. Hubble MJ, Weale AE, Perez J, et al. Clothing in laminar-flow operating theatres. J Hosp Infect 1996;32:1-7 (Pubitemid 26120027)
2. Woodhead K, Taylor EW, Bannister G, et al. Behaviours and rituals in the operating theatre: a report from the Hospital Infection Society Working Party on Infection Control in Operating Theatres. J Hosp Infect 2002;51:241-55 (Pubitemid 38001874)
3. Maathuis PG, Neut D, Busscher HJ, et al. Perioperative contamination in primary total hip arthroplasty. Clin Orthop Relat Res 2005;433:136-9 (Pubitemid 40489260)
4. Mackain-Bremner AA, Owens K, Wylde V, et al. Adherence to recommendations designed to decrease intra-operative wound contamination. Ann R Coll Surg Engl 2008;90:412-16
5. Kuong EE, Ng FY, Yan CH, et al. Antibiotic prophylaxis after total joint replacements. Hong Kong Med J 2009;15:458-62
6. de Beer J, Petruccelli D, Rotstein C, et al. Antibiotic prophylaxis for total joint replacement surgery: results of a survey of Canadian orthopedic surgeons. Can J Surg 2009;52:E229-34
7. Popat KC, Eltgroth M, Latempa TJ, et al. Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials 2007;28:4880-8 (Pubitemid 47285337)
8. Vander Salm TJ, Okike ON, Pasque MK, et al. Reduction of sternal infection by application of topical vancomycin. J Thorac Cardiovasc Surg 1989;98:618-22 (Pubitemid 19248898)
9. Chiu FY, Chen CM, Lin CF, Lo WH. Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees. J Bone Joint Surg Am 2002;84-A:759-62
10. Malchau H, Herberts P, Ahnfelt L. Prognosis of total hip replacement in Sweden. Follow-up of 92,675 operations performed 1978-1990. Acta Orthop Scand 1993;64:497-506 (Pubitemid 23329852)
11. Engesaeter LB, Lie SA, Espehaug B, et al. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003;74:644-51 (Pubitemid 38067862)
12. Lynch M, Esser MP, Shelley P, Wroblewski BM. Deep infection in Charnley low-friction arthroplasty. Comparison of plain and gentamicin-loaded cement. J Bone Joint Surg Br 1987;69:355-60 (Pubitemid 17098464)
13. Jiranek WA, Hanssen AD, Greenwald AS. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am 2006;88:2487-500 (Pubitemid 44713839)
14. Gogia JS, Meehan JP, Di Cesare PE, Jamali AA. Local antibiotic therapy in osteomyelitis. Semin Plast Surg 2009;23:100-7
15. Nelson CL. The current status of material used for depot delivery of drugs. Clin Orthop Relat Res 2004;427:72-8 (Pubitemid 39362834)
16. Bloomfield MR, Klika AK, Barsoum WK. Antibiotic-coated spacers for total hip arthroplasty infection. Orthopedics 2010;33:649
17. Liu SJ, Wen-Neng Ueng S, Lin SS, Chan EC. In vivo release of vancomycin from biodegradable beads. J Biomed Mater Res 2002;63:807-13
18. McLaren AC. Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin Orthop Relat Res 2004;427:101-6 (Pubitemid 39362838)
19. Mader JT, Calhoun J, Cobos J. In vitro evaluation of antibiotic diffusion from antibiotic-impregnated biodegradable beads and polymethylmethacrylate beads. Antimicrob Agents Chemother 1997;41:415-18 (Pubitemid 27111039)
20. Abazinge M, Jackson T, Yang Q, Owusu-Ababio G. Comparison of in vitro and in vivo release characteristics of sustained release ofloxacin microspheres. Drug Deliv 2000;7:77-81 (Pubitemid 30399615)
21. Peng KT, Chen CF, Chu IM, et al. Treatment of osteomyelitis with teicoplanin-encapsulated biodegradable thermosensitive hydrogel nanoparticles. Biomaterials 2010;31:5227-36
22. Krasko MY, Golenser J, Nyska A, et al. Gentamicin extended release from an injectable polymeric implant. J Control Release 2007;117:90-6 (Pubitemid 46172499)
23. Tang L, Zhao C, Xiong Y, Wang A. Preparation, antibacterial properties and biocompatibility studies on vancomycin-poly(D,L)-lactic loaded plates. Int Orthop 2010;34:755-9
24. Gomes PS, Fernandes MH. Effect of therapeutic levels of doxycycline and minocycline in the proliferation and differentiation of human bone marrow osteoblastic cells. Arch Oral Biol 2007;52:251-9 (Pubitemid 46096435)
25. Edin ML, Miclau T, Lester GE, et al. Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res 1996;333:245-51 (Pubitemid 26428036)
26. Ince A, Schutze N, Hendrich C, et al. Effect of polyhexanide and gentamicin on human osteoblasts and endothelial cells. Swiss Med Wkly 2007;137:139-45 (Pubitemid 46465530)
27. Ince A, Schutze N, Karl N, et al. Gentamicin negatively influenced osteogenic function in vitro. Int Orthop 2007;31:223-8 (Pubitemid 46731529)
28. Chang Y, Goldberg VM, Caplan AI. Toxic effects of gentamicin on marrow-derived human mesenchymal stem cells. Clin Orthop Relat Res 2006;452:242-9 (Pubitemid 44690676)
29. Isefuku S, Joyner CJ, Simpson AH. Gentamicin may have an adverse effect on osteogenesis. J Orthop Trauma 2003;17:212-16 (Pubitemid 36395374)
30. Pedersen JG, Lund B. Effects of gentamicin and monomer on bone. An in vitro study. J Arthroplasty 1988;3:S63-8 (Pubitemid 18263002)
31. Salzmann GM, Naal FD, von Knoch F. Tuebel et al. Effects of cefuroxime on human osteoblasts in vitro. J Biomed Mater Res A 2007;82:462-8 (Pubitemid 47051678)
32. Bettany JT, Wolowacz RG. Tetracycline derivatives induce apoptosis selectively in cultured monocytes and macrophages but not in mesenchymal cells. Adv Dent Res 1998;12:136-43
33. Fife RS, Rougraff BT, Proctor C, Sledge GW Jr. Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells. J Lab Clin Med 1997;130:530-4 (Pubitemid 27526335)
34. Perry AC, Prpa B, Rouse MS, et al. Levofloxacin and trovafloxacin inhibition of experimental fracture-healing. Clin Orthop Relat Res 2003;414:95-100 (Pubitemid 37102140)
35. Holtom PD, Pavkovic SA, Bravos PD, et al. Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro. J Orthop Res 2000;18:721-7
36. Gomes PS, Santos JD, Fernandes MH. Cell-induced response by tetracyclines on human bone marrow colonized hydroxyapatite and Bonelike. Acta Biomater 2008;4:630-7
37. Isefuku S, Joyner CJ, Simpson AH. Toxic effect of rifampicin on human osteoblast-like cells. J Orthop Res 2001;19:950-4 (Pubitemid 32799087)
38. Naal FD, Salzmann GM, von Knoch F, et al. The effects of clindamycin on human osteoblasts in vitro. Arch Orthop Trauma Surg 2008;128:317-23
39. Miclau T, Edin ML, Lester GE, et al. Effect of ciprofloxacin on the proliferation of osteoblast-like MG-63 human osteosarcoma cells in vitro. J Orthop Res 1998;16:509-12 (Pubitemid 28427703)
40. Miclau T, Edin ML, Lester GE, et al. Bone toxicity of locally applied aminoglycosides. J Orthop Trauma 1995;9:401-6
41. Huddleston PM, Steckelberg JM, Hanssen AD, et al. Ciprofloxacin inhibition of experimental fracture healing. J Bone Joint Surg Am 2000;82:161-73 (Pubitemid 30097016)
42. Sansone JM, Wilsman NJ, Leiferman EM, et al. The effect of fluoroquinolone antibiotics on growing cartilage in the lamb model. J Pediatr Orthop 2009;29:189-95
43. Galjour C, Dzugan S, Graves M, et al. Stimulation of fracture healing by continuous delivery of demineralized bone matrix proteins and tobramycin. Biomed Sci Instrum 2005;41:122-7
44. Haleem AA, Rouse MS, Lewallen DG, et al. Gentamicin and vancomycin do not impair experimental fracture healing. Clin Orthop Relat Res 2004;427:22-4 (Pubitemid 39362825)
45. Tuncay I, Ozbek H, Kosem M, Unal O. A comparison of effects of fluoroquinolones on fracture healing (an experimental study in rats). Ulus Travma Acil Cerrahi Derg 2005;111:17-22 (Pubitemid 40283359)
46. Dagan R. Fluoroquinolones in paediatrics-1995. Drugs 1995;49:92-9
47. Antoci V Jr, Adams CS, Hickok NJ, et al. Antibiotics for local delivery systems cause skeletal cell toxicity in vitro. Clin Orthop Relat Res 2007;462:200-6 (Pubitemid 47367864)
48. Schentag J.J. Clinical pharmacology of the fluoroquinolones: studies in human dynamic/kinetic models. Clin Infect Dis 2000;31:S40-4 (Pubitemid 32269608)
49. McEvoy G. AHFS drug Information. American Society of Health-System Pharmacists. ASHP; 2010
50. Hoffler D. The pharmacokinetics of amoxicillin. Adv Clin Pharmacol 1974;7:28-30
51. Plaisance KI, Drusano GL, Forrest A, et al. Pharmacokinetic evaluation of two dosage regimens of clindamycin phosphate. Antimicrob Agents Chemother 1989;33:618-20 (Pubitemid 19119999)
52. Dupon M, Janvier G, Vincon G, et al. Plasma levels of piperacillin and vancomycin used as prophylaxis in liver transplant patients. Eur J Clin Pharmacol 1993;45:529-34 (Pubitemid 24036930)
53. Leader WG, Chandler MH, Castiglia M. Pharmacokinetic optimisation of vancomycin therapy. Clin Pharmacokinet 1995;28:327-42
54. Foord RD. Cefuroxime: human pharmacokinetics. Antimicrob Agents Chemother 1976;9:741-7
55. Brogden RN, Heel RC, Speight TM, Avery GS. Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs 1979;17:233-66 (Pubitemid 9155179)
56. Adams K, Couch L, Cierny G, et al. In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads. Clin Orthop Relat Res 1992;278:244-52
57. Mutimer J, Gillespie G, Lovering AM, Porteous AJ. Measurements of in vivo intra-articular gentamicin levels from antibiotic loaded articulating spacers in revision total knee replacement. Knee 2009;16:39-41
58. Wahlig H, Dingeldein E, Bergmann R, Reuss K. The release of gentamicin from polymethylmethacrylate beads. An experimental and pharmacokinetic study. J Bone Joint Surg Br 1978;60:270-5 (Pubitemid 8356875)
59. Stevens CM, Tetsworth KD, Calhoun JH, Mader JT. An articulated antibiotic spacer used for infected total knee arthroplasty: a comparative in vitro elution study of Simplex and Palacos bone cements. J Orthop Res 2005;23:27-33 (Pubitemid 40045073)
60. Nelson CL, McLaren SG, Skinner RA, et al. The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets. J Orthop Res 2002;20:643-7 (Pubitemid 34822981)
61. Hsieh PH, Chang YH, Chen SH, et al. High concentration and bioactivity of vancomycin and aztreonam eluted from Simplex cement spacers in two-stage revision of infected hip implants: a study of 46 patients at an average follow-up of 107 days. J Orthop Res 2006;24:1615-21
62. DiCicco M, Duong T, Chu A, Jansen SA. Tobramycin and gentamicin elution analysis between two in situ polymerizable orthopedic composites. J Biomed Mater Res B Appl Biomater 2003;65:137-49 (Pubitemid 37521386)
63. Mohd Fuad D, Masbah O, Shahril Y, et al. Biomechanical properties of bone cement with addition of cefuroxime antibiotic. Med J Malaysia 2006;61:27-9 (Pubitemid 44196912)
64. Lewis G, Janna S, Bhattaram A. Influence of the method of blending an antibiotic powder with an acrylic bone cement powder on physical, mechanical, and thermal properties of the cured cement. Biomaterials 2005;26:4317-25 (Pubitemid 40430860)
65. Penner MJ, Masri BA, Duncan CP. Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty 1996;11:939-44
66. Baker AS, Greenham LW. Release of gentamicin from acrylic bone cement. Elution and diffusion studies. J Bone Joint Surg Am 1988;70:1551-7 (Pubitemid 19038650)
67. Lewis G, Janna S. The in vitro elution of gentamicin sulfate from a commercially available gentamicin-loaded acrylic bone cement, VersaBond AB. J Biomed Mater Res B Appl Biomater 2004;71:77-83 (Pubitemid 39299406)
68. Penner MJ, Duncan CP, Masri BA. The in vitro elution characteristics of antibiotic-loaded CMW and Palacos-R bone cements. J Arthroplasty 1999;14:209-14 (Pubitemid 29095966)
69. Powles JW, Spencer RF, Lovering AM. Gentamicin release from old cement during revision hip arthroplasty. J Bone Joint Surg Br 1998;80:607-10 (Pubitemid 28351970)
70. Anagnostakos K, Wilmes P, Schmitt E, Kelm J. Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo. Acta Orthop 2009;80:193-7
71. Hsieh PH, Chang YH, Chen SH, et al. High concentration and bioactivity of vancomycin and aztreonam eluted from Simplex cement spacers in two-stage revision of infected hip implants: a study of 46 patients at an average follow-up of 107 days. J Orthop Res 2006;24:1615-21
72. Chohfi M, Langlais F, Fourastier J, et al. Pharmacokinetics, uses, and limitations of vancomycin-loaded bone cement. Int Orthop 1998;22:171-7 (Pubitemid 28388731)
73. Sterling GJ, Crawford S, Potter JH, et al. The pharmacokinetics of Simplex-tobramycin bone cement. J Bone Joint Surg Br 2003;85:646-9 (Pubitemid 36927025)
74. Forsythe ME, Crawford S, Sterling GJ, et al. Safeness of Simplex-tobramycin bone cement in patients with renal dysfunction undergoing total hip replacement. J Orthop Surg (Hong Kong) 2006;14:38-42
75. Crider KS, Cleves MA, Reefhuis J, et al. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med 2009;163:978-85
76. Pountos I, Giannoudis PV, Jones E, et al. NSAIDS inhibit in vitro MSC chondrogenesis but not osteogenesis: implications for mechanism of bone formation inhibition in man. J Cell Mol Med 2011;15:525-34
77. Pountos I, Georgouli T, Blokhuis TJ, et al. Pharmacological agents and impairment of fracture healing: what is the evidence? Injury 2008;39:384-94
78. Pountos I, Georgouli T, Bird H, Giannoudis PV. Nonsteroidal anti-inflammatory drugs: prostaglandins, indications, and side effects. Int J Interferon Cytokine Mediat Res 2011;3:19-27
79. Engesaeter LB, Espehaug B, Lie SA, et al. Does cement increase the risk of infection in primary total hip arthroplasty? Revision rates in 56,275 cemented and uncemented primary THAs followed for 0-16 years in the Norwegian Arthroplasty Register. Acta Orthop 2006;77:351-8 (Pubitemid 43977388)
80. Espehaug B, Engesaeter LB, Vollset SE, et al. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br 1997;79:590-5 (Pubitemid 127469741)
81. Malchau H, Herberts P, Eisler T, et al. The Swedish Total Hip Replacement Register. J Bone Joint Surg Am 2002;84(Suppl 2):2-20 (Pubitemid 35168331)
82. Moojen DJ, van Hellemondt G, Vogely HC, et al. Incidence of low-grade infection in aseptic loosening of total hip arthroplasty. Acta Orthop 2010; 81(6):667-73
83. Cummins JS, Tomek IM, Kantor SR, et al. Cost-effectiveness of antibiotic-impregnated bone cement used in primary total hip arthroplasty. J Bone Joint Surg Am 2009;91:634-41